Application of PBPK modelling in drug discovery and development at Pfizer

Jones, Hannah M; Dickins, Maurice; Youdim, Kuresh; Gosset, James R; Attkins, Neil J; Hay, Tanya L; Gurrell, Ian K; Logan, Y Raj; Bungay, Peter J; Jones, Barry C; Gardner, Iain B

doi:10.3109/00498254.2011.627477

Cited by 92

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Application of PBPK modelling in drug discovery and development at Pfizer

Jones, Hannah M, Dickins, Maurice, Youdim, Kuresh, Gosset, James R, Attkins, Neil J, Hay, Tanya L, Gurrell, Ian K, Logan, Y Raj, Bungay, Peter J, Jones, Barry C, Gardner, Iain B·2012·Xenobiotica

DOI 10.3109/00498254.2011.627477

Open this paper in CoChat — free account

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.3109/00498254.2011.627477

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Membrane transporters in drug development
The International Transporter Consortium, Giacomini, K. M., Huang, S.-M., Tweedie, D. J., Benet, L. Z., Brouwer, K. L. R., Chu, X., Dahlin, A., Evers, R., Fischer, V., et al. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3028 · Cited by 3,340
Physiologically Based Pharmacokinetic Modeling 1: Predicting the Tissue Distribution of Moderate-to-Strong Bases
Rodgers, T., Leahy, D., & Rowland, M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20322 · Cited by 776
Predicting the Impact of Physiological and Biochemical Processes on Oral Drug Bioavailability
Agoram, B., Woltosz, W. S., & Bolger, M. B. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00179-x · Cited by 651
Prediction of the Clearance of Eleven Drugs and Associated Variability in Neonates, Infants and Children
Johnson, T. N., Rostami-Hodjegan, A., & Tucker, G. T. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645090-00005 · Cited by 530
Prediction of in vivo drug metabolism in the human liver from in vitro metabolism data
Iwatsubo, T., Hirota, N., Ooie, T., Suzuki, H., Shimada, N., Chiba, K., Ishizaki, T., Green, C. E., Tyson, C. A., & Sugiyama, Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00184-2 · Cited by 479
Development and Evaluation of a Generic Physiologically Based Pharmacokinetic Model for Children
Edginton, A. N., Schmitt, W., & Willmann, S. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645100-00005 · Cited by 357
A Novel Strategy for Physiologically Based Predictions of Human Pharmacokinetics
Jones, H. M., Parrott, N., Jorga, K., & Lav??, T. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645050-00006 · Cited by 352
Self-citation
Prediction of in vivo drug clearance from in vitro data. I: Impact of inter-individual variability
Howgate, E. M., Rowland Yeo, K., Proctor, N. J., Tucker, G. T., & Rostami-Hodjegan, A. (2006) · Xenobiotica · doi:10.1080/00498250600683197 · Cited by 223
Simulation of Human Intravenous and Oral Pharmacokinetics of 21 Diverse Compounds Using Physiologically Based Pharmacokinetic Modelling
Jones, H. M., Gardner, I. B., Collard, W. T., Stanley, P. J., Oxley, P., Hosea, N. A., Plowchalk, D., Gernhardt, S., Lin, J., Dickins, M., et al. (2011) · Clinical Pharmacokinetics · doi:10.2165/11539680-000000000-00000 · Cited by 110
Self-citation
An Evaluation of the Utility of Physiologically Based Models of Pharmacokinetics in Early Drug Discovery
Parrott, N., Paquereau, N., Coassolo, P., & Lavé, T. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20419 · Cited by 107

Show all 12 references

Research works printed but not linked: 87

10.1080/00498250802069088 · DOI
Almond LM, 2009, Curr Drug Metab, 10, 420, 10.2174/138920009788498978 · DOI
10.1016/0378-4274(95)03355-O · DOI
Baxter LT, 1994, Cancer Res, 54, 1517
10.1002/jps.10539 · DOI
Björkman S, 2001, J Pharm Sci, 90, 1226, 10.1002/jps.1076 · DOI
10.1111/j.1472-8206.2008.00648.x · DOI
10.3109/03602538409033558 · DOI · Paper page
Brightman FA, 2005, Drug Metab Dispos, 34, 94, 10.1124/dmd.105.004838 · DOI
Brightman FA, 2005, Drug Metab Dispos, 34, 84, 10.1124/dmd.105.004804 · DOI
Bungay PJ, 2011, Drug Metab Dispos, 39, 1396, 10.1124/dmd.110.037234 · DOI
10.1016/j.intimp.2007.10.023 · DOI
10.1124/dmd.106.014027 · DOI
10.1124/dmd.107.015644 · DOI · Paper page
10.1517/17425255.4.9.1143 · DOI
10.2165/00003088-200847110-00005 · DOI
Endres CJ, 2009, Mol Pharm, 6, 1756, 10.1021/mp9002392 · DOI
10.1124/dmd.107.019182 · DOI
10.1007/s10439-005-7410-3 · DOI
10.1038/nature08960 · DOI · Paper page
10.1007/s10928-007-9065-1 · DOI · Paper page
10.1016/j.ejps.2007.03.008 · DOI
10.1111/j.1365-2125.2010.03799.x · DOI
Heiskanen T, 2009, Curr Pharm Des, 15, 988, 10.2174/138161209787581968 · DOI
10.1177/0091270009333209 · DOI · Paper page
10.1016/0006-2952(94)90520-7 · DOI · Paper page
10.3109/03602539709002237 · DOI · Paper page
10.1007/s10928-006-9031-3 · DOI
Inoue S, 2006, Xenobiotica, 36, 499, 10.1080/00498250600683262 · DOI
Ito K, 2004, Pharm Res, 21, 785, 10.1023/B:PHAM.0000026429.12114.7d · DOI
Jamei M, 2009, Drug Metab Pharmacokinet, 24, 53, 10.2133/dmpk.24.53 · DOI · Paper page
10.1208/s12248-009-9099-y · DOI · Paper page
10.2165/11318160-000000000-00000 · DOI
Jones BC, 2009, Prog Med Chem, 47, 239, 10.1016/S0079-6468(08)00206-3 · DOI
10.1208/s12248-009-9088-1 · DOI
10.1124/dmd.104.000125 · DOI
10.2165/00003088-200645120-00006 · DOI
Kletting P, 2009, J Nucl Med, 50, 296, 10.2967/jnumed.108.054189 · DOI
Kletting P, 2010, J Nucl Med, 51, 484, 10.2967/jnumed.109.067546 · DOI
10.1021/mp800128y · DOI
Krishnan K, 1994, Physiologically based pharmacokinetic modeling in toxicology
10.1517/17425250903099649 · DOI
10.2165/00003088-199936030-00003 · DOI · Paper page
10.1124/jpet.104.079319 · DOI
10.1023/A:1007529020774 · DOI
10.1208/s12248-009-9107-2 · DOI
10.1016/S0024-3205(98)00525-6 · DOI
10.5414/CPP46556 · DOI
10.1007/s00228-009-0648-1 · DOI
10.1002/jps.1120 · DOI
Modok S, 2006, Eur J Cancer, 42, 2404, 10.1016/j.ejca.2006.05.020 · DOI
10.2165/00003088-200342100-00002 · DOI · Paper page
Obach RS, 1999, Drug Metab Dispos, 27, 1350, 10.1016/S0090-9556(24)14938-0 · DOI · Paper page
10.1016/j.ejpb.2008.10.019 · DOI
10.1124/dmd.107.019455 · DOI
10.1111/j.1742-7843.2005.pto960308.x · DOI
Peng B, 2001, Antisense Nucleic Acid Drug Dev, 11, 15, 10.1089/108729001750072092 · DOI
10.2165/00003088-200847040-00004 · DOI
Poirier A, 2009, Chem Biodivers, 6, 1975, 10.1002/cbdv.200900116 · DOI
Poulin P, 2011, J Pharm Sci
10.1002/1520-6017(200104)90:4<436::AID-JPS1002>3.0.CO;2-P · DOI
10.1002/(SICI)1520-6017(200001)89:1<16::AID-JPS3>3.0.CO;2-E · DOI
10.1002/jps.10005 · DOI · Paper page
10.1080/10408440390242324 · DOI
Proctor NJ, 2004, Xenobiotica, 34, 151, 10.1080/00498250310001646353 · DOI · Paper page
10.1002/jps.20502 · DOI
10.1007/s11095-006-9210-3 · DOI · Paper page
Rostami-Hodjegan A, 2004, Drug Discovery Today: Technologies, 1, 441, 10.1016/j.ddtec.2004.10.002 · DOI
10.1038/nrd2173 · DOI
Rowland M, 2004, AAPS PharmSci, 6, E6, 10.1208/ps060106 · DOI
10.1146/annurev-pharmtox-010510-100540 · DOI · Paper page
Rowland Yeo K, 2010, Eur J Pharm Sci, 39, 298, 10.1016/j.ejps.2009.12.002 · DOI
10.1021/tx800415j · DOI
10.1517/17425250902835506 · DOI
Tanaka C, 2000, Drug Metab Dispos, 28, 582, 10.1016/S0090-9556(24)15104-5 · DOI
10.1016/S0378-4274(02)00374-0 · DOI
10.1208/s12248-008-9023-x · DOI
10.1002/jps.21918 · DOI
10.1124/jpet.108.146647 · DOI · Paper page
Weiss M, 2007, J Pharm Sci, 96, 913, 10.1002/jps.20739 · DOI
10.1007/s10928-007-9053-5 · DOI
10.1023/B:PHAM.0000003373.72652.c0 · DOI
10.1021/jm030999b · DOI
Yamazaki S, 2011, Drug Metab Dispos, 39, 383, 10.1124/dmd.110.035857 · DOI
10.1016/S0378-5173(99)00147-7 · DOI
10.1080/00498250802017715 · DOI
10.1038/clpt.2010.298 · DOI · Paper page

Physiologically based pharmacokinetic modeling in drug discovery and development: A pharmaceutical industry perspective
Jones, H., Chen, Y., Gibson, C., Heimbach, T., Parrott, N., Peters, S., Snoeys, J., Upreti, V., Zheng, M., & Hall, S. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.37 · Cited by 488
Self-citation
In Silico Modeling of Gastrointestinal Drug Absorption: Predictive Performance of Three Physiologically Based Absorption Models
Sjögren, E., Thörn, H., & Tannergren, C. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00861 · Cited by 98
Predicting Pharmacokinetic Profiles Using in Silico Derived Parameters
Hosea, N. A., & Jones, H. M. (2013) · Molecular Pharmaceutics · doi:10.1021/mp300482w · Cited by 65
Self-citation
The virtue of translational PKPD modeling in drug discovery: selecting the right clinical candidate while sparing animal lives
Bueters, T., Ploeger, B. A., & Visser, S. A. G. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.001 · Cited by 43
Considerations from an international regulatory and pharmaceutical industry (IQ MPS affiliate) workshop on the standardization of complex in vitro models in drug development
Tomlinson, L., Ramsden, D., Leite, S. B., Beken, S., Bonzo, J. A., Brown, P., Candarlioglu, P. L., Chan, T. S., Chen, E., Choi, C. K., et al. (2024) · Advanced Biology · doi:10.1002/adbi.202300131 · Cited by 33
Self-citation

See all 92

Authors: Jones, H. M., Dickins, M., Youdim, K., Gosset, J. R., Attkins, N. J., Hay, T. L., Gurrell, I. K., Logan, Y. R., Bungay, P. J., Jones, B. C., & Gardner, I. B.
Venue: Xenobiotica
Publisher: Informa UK Limited
Published: 2011-10-30
Volume: 42
Issue: 1
Pages: 94-106
ISSN: 0049-8254
1366-5928
DOI: 10.3109/00498254.2011.627477
Cited by: 92
References: 12
Language: en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page: CoChat. (2026). Citation check: Application of PBPK modelling in drug discovery and development at Pfizer. https://app.cochat.ai/papers/10.3109/00498254.2011.627477
The paper: Jones, H. M., Dickins, M., Youdim, K., Gosset, J. R., Attkins, N. J., Hay, T. L., Gurrell, I. K., Logan, Y. R., Bungay, P. J., Jones, B. C., & Gardner, I. B. (2012). Application of PBPK modelling in drug discovery and development at Pfizer. Xenobiotica. https://doi.org/10.3109/00498254.2011.627477

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

Application of PBPK modelling in drug discovery and development at Pfizer

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Metadata

Record

About these checks

How to cite

Data sources